12:00 AM
 | 
Jan 21, 2008
 |  BioCentury  |  Finance

Genentech by the numbers

Genentech by the numbers

Genentech by the numbers
Selected financial data for Genentech (NYSE:DNA) in 4Q07 compared with consensus estimates, 3Q07 and 4Q06. (A) Consensus numbers based on seven analysts for individual product sales and total...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >